Targeted Induction Stem Cell Differentiation Using eToeholds
Stem cells are a type of cells with self-renewal, proliferation, and differentiation capabilities. The proliferation and differentiation of stem cells provide a large number of cell sources for tissue transplantation, cell therapy, and gene therapy. Directed differentiation of stem cells plays an important role in regenerative medicine, repairing aging, damaged or diseased tissues. Stem cell directional differentiation has always been the focus of scientists' research, and the technology of inducing directional differentiation of stem cells is the key technology that determines the success of stem cells in the medical field. Therefore, the exploration of the directional differentiation technology of stem cells has never stopped.
Conventional Techniques for Inducing Directed Differentiation of Stem Cells
Typically, stem cell-directed differentiation is directed by constructing a simulated cell growth microenvironment in vitro. However, the traditional in vitro culture method of stem cells needs to add a variety of growth factors to promote the proliferation and specific differentiation of stem cells. Residual growth factors may stimulate cells to grow abnormally and form tumors. To reduce the risk of cancer, some research teams started with stem cell culture materials and developed a "stem cell nano-culture device" to guide stem cells to differentiate into functional cells with therapeutic efficacy. Given the importance of stem cell differentiation, an efficient and non-carcinogenic risk-free technique for directional induction of stem cell differentiation needs to be developed.
Eukaryotic Toehold Switches in Stem Cell Differentiation
Stem cell therapy refers to the use of stem cells for in vitro culture, proliferation, induction of differentiation, etc., to culture new, normal cells or tissues, and transplant them into the body to replace damaged or dead cells. With the emergence of eukaryotic toehold switches (eToeholds), some scholars have found that the eToeholds technology platform can also promote the in vitro differentiation of stem cells, guiding stem cells along developmental pathways to generate specific cell types for cell therapy and other applications. Transformation of stem and intermediate cells along many differentiated cell lineages is often not very efficient, and eToeholds technology can help enrich the desired cell types. At CD BioSciences, we can provide you with corresponding services based on the eToeholds technology platform.
The Services We Can Provide Based on eToeholds
eToeholds is an RNA-based programmable RNA element suitable for eukaryotes developed by inserting IRES into toehold switches. Using the established eToeholds technology platform, CD BioSciences can provide the design, optimization, and synthesis services of eToeholds RNA elements for specific sequences for scholars engaged in stem cell directional differentiation and stem cell therapy research.
Application of eToeholds to Induce Directed Differentiation of Stem Cells
- Stem cell-targeted drug therapy.
- Use stem cells to differentiate into tissues as disease models for in vitro studies in drug discovery.
- Stem cell therapy for the treatment of blood diseases, neoplastic diseases, skin diseases, ophthalmic diseases, and orthopedic diseases.
Advantages of eToeholds in Stem Cell Differentiation
- Greatly reduces the risk of cancer.
- No need to use excessive growth factors or other chemicals.
CD BioSciences looks forward to providing you with eToeholds-based technical support in your research on directed induced stem cell differentiation. If you are interested in the application of eToeholds in the directed differentiation of stem cells, please feel free to contact us.
Reference
- Zhao, EM.; et al. RNA-responsive elements for eukaryotic translational control [published online ahead of print, 2021 Oct 28]. Nat Biotechnol. 2021, 10.1038/s41587-021-01068-2.